Gesprek : PDP-organisaties over het Product Development Partnership Fonds

De vergadering is geweest

Bekijk dagoverzicht
5 november 2014
14:00 - 15:15 uur
Locatie: Wttewaall van Stoetwegenzaal
Commissie: algemene commissie voor Buitenlandse Handel en Ontwikkelingssamenwerking (2012-2021)

Bijlage

Deelnemers

  • R.P. van Laar (PvdA)
  • I.S.H. de Caluwé (VVD)
  • A.H. (Agnes) Mulder (CDA)
  • E.M.A. Smaling (SP)

Agendapunten

  1. 1

    Gesprek met PDP-organisaties over het Product Development Partnership Fonds (PDP-fonds)

    Naast KNCV Tuberculosefonds, AERAS en IAVI zal ook één vertegenwoordiger van de overige PDP's aan het gesprek deelnemen.
    Het gaat om de volgende PDP's:

    - Drugs for Neglected Diseases Initiative (DNDI)
    - International Partnership for Microbicides
    - Sabin
    - Foundation for Innovative New Diagnostics (FIND)
    - PATH/Protection Options for Women

    PROGRAMME
     
    Epidemiological update on poverty-related and neglected diseases (PRND): the importance of developing new health tools for those who need it most
     
    The importance of product development partnerships in the fight against PRND
     
    • Dr. Lewis Schrager, VP of Scientific Affairs, Aeras
    • Hester Kuipers, Executive Director IAVI Europe

    The value of collaboration with PDPs for Dutch partners from industry & academia
     
    • Prof. Dr. Hanneke Schuitemaker, Head Viral Vaccine Discovery and Translational Medicine, Crucell / Johnson & Johnson
    • Prof. Dr. Peter Peters, Head of institute of Nanoscopy, Maastricht University
     
    Leveraging the power of PPPs to save lives and improve health
     
    • Dr. Mercy Ahun, Special representative to GAVI eligible countries

    Partnerships delivering products against PRND
     
    •  Dr. Tim Wells, Chief Scientific Officer of Medicines for Malaria Venture (MVV)